SP-MHCI-0489-3

HBV genotype C subtype ar (isolate Japan/S-207/1988) Capsid protein 93-100, MGLKFRQL

US$507.00

In stock

Description

About HBV genotype C subtype ar (isolate Japan/S-207/1988) Capsid protein 93-100, MGLKFRQL

The Hepatitis B Virus (HBV) genotype C subtype ar (isolate Japan/S-207/1988) Capsid protein Peptide (IEDB: 41603) is a high quality epitope peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxicity or proliferation assays. The Capsid protein Peptide, H-MGLKFRQL-OH (Uniprot: P0C6H4 aa: 93-100) from JPT is produced under strict quality control and quality management.

HBV genotype C subtype ar (isolate Japan/S-207/1988) Capsid protein 93-100, MGLKFRQL - Specifications

  • Peptide sequence: H-MGLKFRQL-OH
  • Amount: 10 mg (10 x 1 mg)
  • Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
  • Counterion: TFA
  • Delivery Format: Freeze-dried in glass vial
  • Application(s): T-cell Immunity
  • Condition(s)/Topic(s): Hepatitis
  • Standard Delivery Time: approx. 3 weeks

JPT’s Antigen Peptides
Find your antigen peptide and select the connected PepMix™ Peptide Pool for efficient immune monitoring, mapping of T cell epitopes or development of immunotherapy and vaccines. JPT Peptide Technologies has substantial, long-standing expertise in providing peptides, peptidomimetics, and proteins to the global scientific community. Our highly skilled and committed scientific staff ensures that the most appropriate methods and techniques are selected for every synthesis project. All our catalog peptides are provided with HPLC-MS analyses to confirm the identity and demonstrate the high quality of our peptides.
Not found what you are looking for? Take a look at our Peptide Synthesis Services!

Benefits of JPT’s Antigen Peptides
- All peptides are made in Germany
- Bulk orders or custom peptide snythesis upon request
- Synthesis protocols designed to avoid toxic contaminants and side products
- Provision of freeze dried aliquots for enhanced stability
- Proven track record for applications in clinical studies
- Order the connected PepMix™ Peptide Pool with your peptide!

References

References for HBV genotype C subtype ar (isolate Japan/S-207/1988) Capsid protein 93-100, MGLKFRQL

References:
Read References with JPT’s Antigen Peptides
HBV genotype C subtype ar (isolate Japan/S-207/1988) Capsid protein 93-100, MGLKFRQL has been described in:
Recombinant polioviruses expressing hepatitis B virus-specific cytotoxic T-lymphocyte epitopes., Vaccine, 2000 (PMID: 10812231)
DNA vaccination with plasmids encoding the intracellular (HBcAg) or secreted (HBeAg) form of the core protein of hepatitis B virus primes T cell responses to two overlapping Kb- and Kd-restricted epitopes., Int Immunol, 1997 (PMID: 9263018)
Identification of shared tumor epitopes from endogenous retroviruses inducing high-avidity cytotoxic T cells for cancer immunotherapy., Sci Adv, 2022 (PMID: 35080970)

Documentation

Documentation for HBV genotype C subtype ar (isolate Japan/S-207/1988) Capsid protein 93-100, MGLKFRQL

Properties

Properties of HBV genotype C subtype ar (isolate Japan/S-207/1988) Capsid protein 93-100, MGLKFRQL

Properties Values
Application: T-cell immunity
Category: Antigen Peptides
Condition / Topic: Hepatitis
Layout: Freeze-dried in glass vial
Organism: Hepatitis B Virus (HBV)
Protein Name: Capsid protein
Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
Quantification: No, Yes

Further Information to HBV genotype C subtype ar (isolate Japan/S-207/1988) Capsid protein 93-100, MGLKFRQL

Information Values
Sequence: H-MGLKFRQL-OH
Specifications: 8mer peptide as TFA salt
Loading...

Check our list of products, click and go.

Get a quote